Home
Revolution Medicines, Inc.

Revolution Medicines, Inc. Market Share Analysis for July 2026

revolution medicines is an innovative and dynamic organization of experts working together to discover and develop new medicines for cancer patients.

Health > Biotechnology and Pharmaceuticals

Domainrevolutionmedicines.com

Year Founded2014

Employees201 - 500

Annual Revenue$10M - $15M

Revolution Medicines, Inc.

Revolution Medicines, Inc. (including company regionals)

revolutionmedicines.com

See more website traffic and engagement information

Revolution Medicines, Inc. Revenue up to July 2026 is 10M - 15M

revenue generated by Revolution Medicines, Inc. top domains

Revolution Medicines, Inc. top domains revenue over 3 years

Revenue for Revolution Medicines, Inc. top domains

revolutionmedicines.com10M - 15M

See more with Sales Intelligence

Total visits to Revolution Medicines, Inc.'s top domains

Understand Revolution Medicines, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Revolution Medicines, Inc.'s top domains

Analyze Revolution Medicines, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Revolution Medicines, Inc.'s top domains

See how Revolution Medicines, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Revolution Medicines, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Revolution Medicines, Inc.

These are the website technologies, by industry, used by Revolution Medicines, Inc. top domains

Content Management System (4)

WordPress

Mobile (2)

Meta Viewport

Advertising (1)

Awin

Conversion & Analytics (1)

Google Analytics

More Technologies

2

See all

News & Signals from Revolution Medicines, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsREVOLUTION Medicines, Inc. acquires EQRx, Inc..EQRx will be acquired by Revolution Medicines in an all-stock transaction, the companies announced Tuesday morning in a press release.

NewsREVOLUTION Medicines, Inc. launched SHP2 inhibitor on Jan 1st '18.Back in 2018, Revolution Medicines launched its SHP2 inhibitor with a splash thanks to a $550 million licensing deal with Sanofi.